| Field | Row 1 |
|---|---|
| adsh | 0001179929-25-000070 |
| cik | 1179929 |
| name | MOLINA HEALTHCARE, INC. |
| sic | 6324 |
| countryba | US |
| stprba | CA |
| cityba | LONG BEACH |
| zipba | 90802 |
| bas1 | 200 OCEANGATE, SUITE 100 |
| bas2 | |
| baph | 5624353666 |
| countryma | US |
| stprma | CA |
| cityma | LONG BEACH |
| zipma | 90802 |
| mas1 | 200 OCEANGATE, SUITE 100 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 134204626 |
| former | MOLINA HEALTHCARE INC |
| changed | 20020812 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250424 |
| accepted | 2025-04-24 10:05:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | moh-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001179929-25-000070 | 20241231 | Assets | 15630000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Assets | 16386000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4908000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -336000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Common Stock Shares Outstanding | 56000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Common Stock Shares Outstanding | 54000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Common Stock Value Outstanding | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Depreciation And Amortization | 48000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Earnings Per Share Diluted | 5.1700 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Finance Lease Liability Noncurrent | 192000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Contract With Customer Liability | -90000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Interest Expense Nonoperating | 27000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Liabilities | 12076000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Liability For Claims And Claims Adjustment Expense | 4204000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Liability For Claims And Claims Adjustment Expense | 3444000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicaid; | ||
| 0001179929-25-000070 | 20240331 | Liability For Claims And Claims Adjustment Expense | 839000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicare; | ||
| 0001179929-25-000070 | 20241231 | Liability For Claims And Claims Adjustment Expense | 722000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicare; | ||
| 0001179929-25-000070 | 20241231 | Medical Premium Liability Due To Agency | 1874000000.0000 | USD | 0 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Net Cash Provided By Used In Operating Activities | 190000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Net Income Loss | 301000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20250331 | Net Income Loss | 298000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Operating Income Loss | 433000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 29000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Other Liabilities Noncurrent | 120000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Liabilities Noncurrent | 155000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Prepaid Expense And Other Assets Current | 487000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 331000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Share Based Compensation | 27000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Stockholders Equity | 410000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20241231 | Additional Paid In Capital Common Stock | 462000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -28000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Contract With Customer Liability Current | 51000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cost Of Goods And Services Sold | 8414000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cost Of Goods And Services Sold | 418000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Marketplace; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20241231 | Deferred Income Tax Assets Net | 207000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Earnings Per Share Basic | 5.2100 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Health Care Insurance Liabilities | -24000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Health Care Insurance Liabilities | -81000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Intangible Assets Net Including Goodwill | 1938000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Interest Expense Nonoperating | 43000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Liabilities Current | 8155000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Net Investment Income | 108000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -5000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Operating Activities Cash Flow Statement | 2000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Payments To Acquire Businesses Net Of Cash Acquired | 295000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Premiums Earned Net | 7492000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicaid; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Premium Tax Expenses | 388000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 211000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Share Repurchase Program Excise Tax | 5000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20231231 | Stockholders Equity | 3887000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20240331 | Stockholders Equity | -85000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Stockholders Equity | 3904000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Value | 485000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20250331 | Additional Paid In Capital Common Stock | 434000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Cash And Cash Equivalents At Carrying Value | 4662000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Common Stock Shares Outstanding | 54000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Common Stock Value Outstanding | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Comprehensive Income Net Of Tax | 298000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Contract With Customer Liability Current | 369000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Cost Of Goods And Services Sold | 9479000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Deferred Income Tax Assets Net | 193000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Depreciation And Amortization | 45000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Earnings Per Share Diluted | 5.4500 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | 65000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | 77000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Deferred Income Taxes | -26000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Medical Premium Liability Due To Agency | 183000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20241231 | Liability For Claims And Claims Adjustment Expense | 3667000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicaid; | ||
| 0001179929-25-000070 | 20250331 | Liability For Claims And Claims Adjustment Expense | 415000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Marketplace; | ||
| 0001179929-25-000070 | 20250331 | Net Investment Income | 108000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Other Assets Noncurrent | 138000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -3000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | 10000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Income | 22000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Income | 23000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Premiums Earned Net | 9504000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Premiums Earned Net | 570000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Marketplace; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Premiums Earned Net | 26000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Program; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Prepaid Expense And Other Assets Current | 472000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Proceeds From Long Term Lines Of Credit | 150000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 287000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Retained Earnings Accumulated Deficit | 3904000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stockholders Equity | 4310000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stockholders Equity | -28000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Shares | 2000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Value | 500000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4741000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Common Stock Shares Outstanding | 56000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Common Stock Withheld To Settle Employee Tax Obligations | 36000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Cost Of Goods And Services Sold | 7339000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicaid; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Cost Of Goods And Services Sold | 1296000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicare; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20240331 | Depreciation Depletion And Amortization | 45000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Finance Lease Liability Noncurrent | 195000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 390000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Medical Premium Liability Due To Agency | -32000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20241231 | Liabilities And Stockholders Equity | 15630000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Liabilities And Stockholders Equity | 16386000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Liability For Claims And Claims Adjustment Expense | 532000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicare; | ||
| 0001179929-25-000070 | 20240331 | Liability For Claims And Claims Adjustment Expense | 246000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Marketplace; | ||
| 0001179929-25-000070 | 20241231 | Liability For Claims And Claims Adjustment Expense | 4640000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Liability For Claims And Claims Adjustment Expense | 4804000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Net Cash Provided By Used In Financing Activities | -62000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Net Cash Provided By Used In Financing Activities | 147000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Premiums Earned Net | 10628000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Proceeds From Issuance Of Other Long Term Debt | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Proceeds From Payments For Other Financing Activities | -6000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Restricted Investments Noncurrent | 286000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Stockholders Equity | 4496000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Shares | 1679000.0000 | shares | 1 | us-gaap/2024 | Share Repurchase Program= Common Stock Repurchase Program October2024; | ||
| 0001179929-25-000070 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -57000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Assets Current | 12773000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4955000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cost Of Goods And Services Sold | 6717000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicaid; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Cost Of Goods And Services Sold | 821000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Marketplace; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Costs And Expenses | 10714000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Health Care Organization Premium Tax Revenue | 388000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 56000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Liabilities | 11134000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Liabilities Current | 7896000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Liability For Claims And Claims Adjustment Expense | 796000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicare; | ||
| 0001179929-25-000070 | 20250331 | Other Assets Noncurrent | 163000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Cost And Expense Operating | 25000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Operating Activities Cash Flow Statement | 2000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Payments For Proceeds From Other Investing Activities | -3000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Payments For Repurchase Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Payments To Acquire Marketable Securities | 380000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Payments To Acquire Marketable Securities | 189000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Premiums Earned Net | 8130000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicaid; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Premiums Earned Net | 1468000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicare; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20241231 | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 288000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Receivables Net Current | 3491000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Revenues | 9931000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Share Based Compensation | 36000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Stockholders Equity | 4215000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Value | 15000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20250331 | Assets Current | 13257000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cash And Cash Equivalents At Carrying Value | 4513000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Common Stock Shares Outstanding | 59000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20240331 | Cost Of Goods And Services Sold | 1279000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicare; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20240331 | Costs And Expenses | 9505000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Depreciation Depletion And Amortization | 48000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Health Care Organization Premium Tax Revenue | 297000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Income Tax Expense Benefit | 92000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -268000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -8000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Receivables | 123000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Liability For Claims And Claims Adjustment Expense | 228000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Marketplace; | ||
| 0001179929-25-000070 | 20250331 | Liability For Claims And Claims Adjustment Expense | 3566000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicaid; | ||
| 0001179929-25-000070 | 20250331 | Marketable Securities Current | 4438000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Medical Premium Liability Due To Agency | 1863000000.0000 | USD | 0 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Net Cash Provided By Used In Investing Activities | -123000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Operating Income Loss | 426000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 29000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20250331 | Payments To Acquire Property Plant And Equipment | 22000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Premiums Earned Net | 1442000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Medicare; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Proceeds From Issuance Of Other Long Term Debt | 500000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Receivables Net Current | 2223000000.0000 | USD | 0 | us-gaap/2024 | Accounts Notes Loans And Financing Receivable By Receivable Type= Government Receivables; | ||
| 0001179929-25-000070 | 20250331 | Receivables Net Current | 2265000000.0000 | USD | 0 | us-gaap/2024 | Accounts Notes Loans And Financing Receivable By Receivable Type= Government Receivables; | ||
| 0001179929-25-000070 | 20241231 | Retained Earnings Accumulated Deficit | 4091000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Share Repurchase Program Excise Tax | 5000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20250331 | Stock Repurchased And Retired During Period Value | 500000000.0000 | USD | 1 | us-gaap/2024 | Share Repurchase Program= Common Stock Repurchase Program October2024; | ||
| 0001179929-25-000070 | 20240331 | Net Cash Provided By Used In Investing Activities | -488000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Accounts Payable And Accrued Liabilities Current | 1119000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cost Of Goods And Services Sold | 0.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Program; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Cost Of Goods And Services Sold | 23000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Program; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20250331 | Earnings Per Share Basic | 5.4700 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | General And Administrative Expense | 774000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 399000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Income Tax Expense Benefit | 98000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -215000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Receivables | 90000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Liability For Claims And Claims Adjustment Expense | 3486000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Medicaid; | ||
| 0001179929-25-000070 | 20241231 | Liability For Claims And Claims Adjustment Expense | 0.0000 | USD | 0 | us-gaap/2024 | Business Segments= Other Program; | ||
| 0001179929-25-000070 | 20250331 | Liability For Claims And Claims Adjustment Expense | 27000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Other Program; | ||
| 0001179929-25-000070 | 20241231 | Long Term Debt Noncurrent | 2923000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Marketable Securities Current | 4325000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Net Income Loss | 298000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -3000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | 39000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Payments For Proceeds From Other Investing Activities | -2000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Payments For Repurchase Of Common Stock | 500000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Premiums Earned Net | 0.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Program; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20240331 | Proceeds From Long Term Lines Of Credit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Proceeds From Payments For Other Financing Activities | 33000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Receivables Net Current | 3299000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Revenues | 11147000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Stockholders Equity | 4493000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Stockholders Equity | 390000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20241231 | Stockholders Equity | 4091000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 1000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20240331 | Stock Issued During Period Value Share Based Compensation | -20000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Stock Issued During Period Value Share Based Compensation | -20000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20250331 | Stock Issued During Period Value Share Based Compensation | -8000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Stock Issued During Period Value Share Based Compensation | -8000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20250430 | Stock Repurchased And Retired During Period Shares | 0.0000 | shares | 0 | us-gaap/2024 | Share Repurchase Program= Common Stock Repurchase Program April2025; Subsequent Event Type= Subsequent Event; | ||
| 0001179929-25-000070 | 20241231 | Accounts Payable And Accrued Liabilities Current | 1331000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20241231 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4856000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4572000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 214000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Common Stock Shares Outstanding | 58000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001179929-25-000070 | 20240331 | Common Stock Withheld To Settle Employee Tax Obligations | 56000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Comprehensive Income Net Of Tax | 327000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | General And Administrative Expense | 711000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Contract With Customer Liability | 252000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Increase Decrease In Deferred Income Taxes | -13000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Intangible Assets Net Including Goodwill | 2175000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Liability For Claims And Claims Adjustment Expense | 0.0000 | USD | 0 | us-gaap/2024 | Business Segments= Other Program; | ||
| 0001179929-25-000070 | 20240331 | Liability For Claims And Claims Adjustment Expense | 4571000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Liability For Claims And Claims Adjustment Expense | 0.0000 | USD | 0 | us-gaap/2024 | Business Segments= Other Program; | ||
| 0001179929-25-000070 | 20241231 | Liability For Claims And Claims Adjustment Expense | 251000000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Marketplace; | ||
| 0001179929-25-000070 | 20250331 | Long Term Debt Noncurrent | 3574000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Net Cash Provided By Used In Operating Activities | 214000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Net Income Loss | 301000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | -2000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Other Cost And Expense Operating | 38000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Payments To Acquire Businesses Net Of Cash Acquired | 245000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20240331 | Payments To Acquire Property Plant And Equipment | 27000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20250331 | Premiums Earned Net | 1004000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Marketplace; Consolidation Items= Operating Segments; | ||
| 0001179929-25-000070 | 20240331 | Premium Tax Expenses | 297000000.0000 | USD | 1 | 0001179929-25-000070 | |||
| 0001179929-25-000070 | 20250331 | Restricted Investments Noncurrent | 311000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001179929-25-000070 | 20231231 | Stockholders Equity | -82000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20240331 | Stockholders Equity | 4188000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001179929-25-000070 | 20241231 | Stockholders Equity | -57000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001179929-25-000070 | 20241231 | Stockholders Equity | 462000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001179929-25-000070 | 20250331 | Stockholders Equity | 434000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Premium Tax Expenses | 0001179929-25-000070 | 1 | 0 | monetary | D | D | Premium Tax Expenses | An assessment levied by a state government on the net premium income collected. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Businesses, Net of Cash Acquired | The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Finance Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Income | Amount of revenue and income classified as other. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stock Repurchased And Retired During Period Value | us-gaap/2024 | 0 | 0 | monetary | D | D | Stock Repurchased and Retired During Period, Value | Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Increase Decrease In Receivables | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Receivables | The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities. |
| Intangible Assets Net Including Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Including Goodwill) | Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Operating Activities Cash Flow Statement | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Operating Activities, Cash Flow Statement | Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities). |
| Receivables Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Receivables, Net, Current | The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. |
| Restricted Investments Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Investments, Noncurrent | This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Payments For Proceeds From Other Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for (Proceeds from) Other Investing Activities | Amount of cash (inflow) outflow from investing activities classified as other. |
| Stock Repurchased And Retired During Period Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Repurchased and Retired During Period, Shares | Number of shares that have been repurchased and retired during the period. | |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Other Cost And Expense Operating | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Cost and Expense, Operating | The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Increase Decrease In Medical Premium Liability Due To Agency | 0001179929-25-000070 | 1 | 0 | monetary | D | D | Increase (Decrease) In Medical Premium Liability Due To Agency | Increase (Decrease) in Medical Premium Liability Due to Agency |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Health Care Insurance Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Health Care Insurance Liabilities | The increase (decrease) in health care insurance liability balances during the period. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Premiums Earned Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Premiums Earned, Net | Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. |
| Common Stock Withheld To Settle Employee Tax Obligations | 0001179929-25-000070 | 1 | 0 | monetary | D | C | Common Stock Withheld to Settle Employee Tax Obligations | Common Stock Withheld to Settle Employee Tax Obligations |
| Health Care Organization Premium Tax Revenue | 0001179929-25-000070 | 1 | 0 | monetary | D | C | Health Care Organization, Premium Tax Revenue | Health Care Organization, Premium Tax Revenue |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Increase Decrease In Deferred Income Taxes | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Income Taxes | The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa. |
| Liability For Claims And Claims Adjustment Expense | us-gaap/2024 | 0 | 0 | monetary | I | C | Liability for Claims and Claims Adjustment Expense | The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Proceeds From Issuance Of Other Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Other Long-Term Debt | Amount of cash inflow from issuance of long-term debt classified as other. |
| Proceeds From Long Term Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Long-Term Lines of Credit | The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer. |
| Proceeds From Payments For Other Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization | Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Share Repurchase Program Excise Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | Share Repurchase Program, Excise Tax | Amount of excise tax on share purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments For Repurchase Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Common Stock Value Outstanding | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Outstanding | Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares. |
| Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Net Investment Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Investment Income | Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Medical Premium Liability Due To Agency | 0001179929-25-000070 | 1 | 0 | monetary | I | C | Medical Premium Liability Due To Agency | Medical Premium Liability Due to Agency |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001179929-25-000070 | 2 | 2 | IS | 0 | H | Premiums Earned Net | us-gaap/2024 | Premium revenue | 0 |
| 0001179929-25-000070 | 2 | 3 | IS | 0 | H | Health Care Organization Premium Tax Revenue | 0001179929-25-000070 | Premium tax revenue | 0 |
| 0001179929-25-000070 | 2 | 4 | IS | 0 | H | Net Investment Income | us-gaap/2024 | Investment income | 0 |
| 0001179929-25-000070 | 2 | 5 | IS | 0 | H | Other Income | us-gaap/2024 | Other revenue | 0 |
| 0001179929-25-000070 | 2 | 6 | IS | 0 | H | Revenues | us-gaap/2024 | Total revenue | 0 |
| 0001179929-25-000070 | 2 | 8 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Medical care costs | 0 |
| 0001179929-25-000070 | 2 | 9 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001179929-25-000070 | 2 | 10 | IS | 0 | H | Premium Tax Expenses | 0001179929-25-000070 | Premium tax expenses | 0 |
| 0001179929-25-000070 | 2 | 11 | IS | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001179929-25-000070 | 2 | 12 | IS | 0 | H | Other Cost And Expense Operating | us-gaap/2024 | Other | 0 |
| 0001179929-25-000070 | 2 | 13 | IS | 0 | H | Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001179929-25-000070 | 2 | 14 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating income | 0 |
| 0001179929-25-000070 | 2 | 15 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 0 |
| 0001179929-25-000070 | 2 | 16 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income before income tax expense | 0 |
| 0001179929-25-000070 | 2 | 17 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 0 |
| 0001179929-25-000070 | 2 | 18 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001179929-25-000070 | 2 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net income per share - Basic (in dollars per share) | 0 |
| 0001179929-25-000070 | 2 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net income per share - Diluted (in dollars per share) | 0 |
| 0001179929-25-000070 | 3 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001179929-25-000070 | 3 | 3 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | us-gaap/2024 | Unrealized investment gain (loss) | 0 |
| 0001179929-25-000070 | 3 | 4 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | Less: effect of income taxes | 0 |
| 0001179929-25-000070 | 3 | 5 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive gain (loss), net of tax | 0 |
| 0001179929-25-000070 | 3 | 6 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income | 0 |
| 0001179929-25-000070 | 4 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001179929-25-000070 | 4 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Investments | 0 |
| 0001179929-25-000070 | 4 | 5 | BS | 0 | H | Receivables Net Current | us-gaap/2024 | Receivables | 0 |
| 0001179929-25-000070 | 4 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001179929-25-000070 | 4 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001179929-25-000070 | 4 | 8 | BS | 0 | H | Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | us-gaap/2024 | Property, equipment, and capitalized software, net | 0 |
| 0001179929-25-000070 | 4 | 9 | BS | 0 | H | Intangible Assets Net Including Goodwill | us-gaap/2024 | Goodwill, and intangible assets, net | 0 |
| 0001179929-25-000070 | 4 | 10 | BS | 0 | H | Restricted Investments Noncurrent | us-gaap/2024 | Restricted investments | 0 |
| 0001179929-25-000070 | 4 | 11 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred income taxes, net | 0 |
| 0001179929-25-000070 | 4 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001179929-25-000070 | 4 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001179929-25-000070 | 4 | 16 | BS | 0 | H | Liability For Claims And Claims Adjustment Expense | us-gaap/2024 | Medical claims and benefits payable | 0 |
| 0001179929-25-000070 | 4 | 17 | BS | 0 | H | Medical Premium Liability Due To Agency | 0001179929-25-000070 | Amounts due government agencies | 0 |
| 0001179929-25-000070 | 4 | 18 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable, accrued liabilities and other | 0 |
| 0001179929-25-000070 | 4 | 19 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Deferred revenue | 0 |
| 0001179929-25-000070 | 4 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001179929-25-000070 | 4 | 21 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term debt | 0 |
| 0001179929-25-000070 | 4 | 22 | BS | 0 | H | Finance Lease Liability Noncurrent | us-gaap/2024 | Finance lease liabilities | 0 |
| 0001179929-25-000070 | 4 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0001179929-25-000070 | 4 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001179929-25-000070 | 4 | 26 | BS | 0 | H | Common Stock Value Outstanding | us-gaap/2024 | Common stock, $0.001 par value, 150 million shares authorized; outstanding: 54 million shares at March 31, 2025 and $56 million at December 31, 2024 | 0 |
| 0001179929-25-000070 | 4 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding | 0 |
| 0001179929-25-000070 | 4 | 28 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001179929-25-000070 | 4 | 29 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0001179929-25-000070 | 4 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings | 0 |
| 0001179929-25-000070 | 4 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001179929-25-000070 | 4 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001179929-25-000070 | 5 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001179929-25-000070 | 5 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001179929-25-000070 | 5 | 3 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
| 0001179929-25-000070 | 5 | 4 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001179929-25-000070 | 5 | 5 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001179929-25-000070 | 5 | 6 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001179929-25-000070 | 5 | 7 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001179929-25-000070 | 6 | 10 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001179929-25-000070 | 6 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001179929-25-000070 | 6 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001179929-25-000070 | 6 | 13 | EQ | 0 | H | Stock Repurchased And Retired During Period Shares | us-gaap/2024 | Common stock purchases (in shares) | 1 |
| 0001179929-25-000070 | 6 | 14 | EQ | 0 | H | Stock Repurchased And Retired During Period Value | us-gaap/2024 | Common stock purchases | 1 |
| 0001179929-25-000070 | 6 | 15 | EQ | 0 | H | Share Repurchase Program Excise Tax | us-gaap/2024 | Stock purchase excise tax | 1 |
| 0001179929-25-000070 | 6 | 16 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss), net | 0 |
| 0001179929-25-000070 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Share-based compensation (in shares) | 0 |
| 0001179929-25-000070 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001179929-25-000070 | 6 | 19 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001179929-25-000070 | 6 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001179929-25-000070 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001179929-25-000070 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001179929-25-000070 | 7 | 5 | CF | 0 | H | Increase Decrease In Deferred Income Taxes | us-gaap/2024 | Deferred income taxes | 1 |
| 0001179929-25-000070 | 7 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001179929-25-000070 | 7 | 7 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2024 | Other, net | 0 |
| 0001179929-25-000070 | 7 | 9 | CF | 0 | H | Increase Decrease In Receivables | us-gaap/2024 | Receivables | 1 |
| 0001179929-25-000070 | 7 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001179929-25-000070 | 7 | 11 | CF | 0 | H | Increase Decrease In Health Care Insurance Liabilities | us-gaap/2024 | Medical claims and benefits payable | 0 |
| 0001179929-25-000070 | 7 | 12 | CF | 0 | H | Increase Decrease In Medical Premium Liability Due To Agency | 0001179929-25-000070 | Amounts due government agencies | 0 |
| 0001179929-25-000070 | 7 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued liabilities and other | 0 |
| 0001179929-25-000070 | 7 | 14 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0001179929-25-000070 | 7 | 15 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income taxes | 0 |
| 0001179929-25-000070 | 7 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by operating activities | 0 |
| 0001179929-25-000070 | 7 | 18 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of investments | 1 |
| 0001179929-25-000070 | 7 | 19 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Proceeds from sales and maturities of investments | 0 |
| 0001179929-25-000070 | 7 | 20 | CF | 0 | H | Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2024 | Net cash paid in business combinations | 1 |
| 0001179929-25-000070 | 7 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property, equipment and capitalized software | 1 |
| 0001179929-25-000070 | 7 | 22 | CF | 0 | H | Payments For Proceeds From Other Investing Activities | us-gaap/2024 | Other, net | 1 |
| 0001179929-25-000070 | 7 | 23 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001179929-25-000070 | 7 | 25 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2024 | Common stock purchases | 1 |
| 0001179929-25-000070 | 7 | 26 | CF | 0 | H | Proceeds From Long Term Lines Of Credit | us-gaap/2024 | Proceeds from borrowings under credit facility | 0 |
| 0001179929-25-000070 | 7 | 27 | CF | 0 | H | Proceeds From Issuance Of Other Long Term Debt | us-gaap/2024 | Proceeds from borrowings under term loan | 0 |
| 0001179929-25-000070 | 7 | 28 | CF | 0 | H | Common Stock Withheld To Settle Employee Tax Obligations | 0001179929-25-000070 | Common stock withheld to settle employee tax obligations | 1 |
| 0001179929-25-000070 | 7 | 29 | CF | 0 | H | Proceeds From Payments For Other Financing Activities | us-gaap/2024 | Other, net | 0 |
| 0001179929-25-000070 | 7 | 30 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0001179929-25-000070 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 0 |
| 0001179929-25-000070 | 7 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 0 |
| 0001179929-25-000070 | 7 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents, and restricted cash and cash equivalents at end of period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |